Mark W. LaMere

926 citations
17 papers · 613 indexed · h-index 5
Topics
Acute Myeloid Leukemia Research (9 papers)Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers)Mesenchymal stem cell research (3 papers)

In The Last Decade

Mark W. LaMere

17 papers receiving 609 citations

Peers

Mark W. LaMere
Comparison fields: 5 of 50
  • Epidemiology 239
  • Immunology 239
  • Molecular Biology 221
  • Hematology 207
  • Infectious Diseases 60
Replace Henrike Reinhard with:
Henrike Reinhard Germany
Amber van Stijn Netherlands
Evelien Naessens Belgium
Laure Gineau France
R M Hesselton United States
Sören Reinke United Kingdom
Mieke Sprangers Germany
María Virginia Tribulatti Argentina
Kathy Buttigieg Australia
Danillo G. Augusto Brazil
Mark W. LaMere relative to Henrike Reinhard Germany Henrike Reinhard's profile →
Citations per field
00.5×1.5×2.0×
Henrike Reinhard · 1×
Citations per year

Countries citing papers authored by Mark W. LaMere

Since Specialization
Citations

This map shows the geographic impact of Mark W. LaMere's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark W. LaMere with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark W. LaMere more than expected).

Fields of papers citing papers by Mark W. LaMere

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark W. LaMere. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark W. LaMere. The network helps show where Mark W. LaMere may publish in the future.

Co-authorship network of co-authors of Mark W. LaMere

This figure shows the co-authorship network connecting the top 25 collaborators of Mark W. LaMere. A scholar is included among the top collaborators of Mark W. LaMere based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark W. LaMere. Mark W. LaMere is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
#WorkIndexed citations
1 3
2 2
3 1
4 1
5 93
6 1
7 2
8 2
9 1
10 4
11 166
12 67
13 1
14 1
15 1
16 94
17 173

About Mark W. LaMere

Mark W. LaMere is a scholar working on Hematology, Genetics and Clinical Biochemistry, having authored 17 papers that have together received 613 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (9 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers) and Mesenchymal stem cell research (3 papers). The work is most often cited by research in Hematology (207 citations), Immunology (239 citations) and Epidemiology (239 citations). Mark W. LaMere has collaborated with scholars based in United States, Japan and South Korea. Frequent co-authors include Denise A. Kaminski, Amy Moquin, Troy D. Randall, Frances E. Lund, Laura Haynes, Michael W. Becker, Tzu‐Chieh Ho, John M. Ashton, Jane L. Liesveld and Eunice S. Wang. Their work appears in journals such as Blood, The Journal of Immunology and Journal of Virology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026